PIL - Verapamil Tablets BP 40mg, 80mg, 120mg, 160mg: Change history
View Patient Information Leaflet (PIL - Verapamil Tablets BP 40mg, 80mg, 120mg, 160mg)
Last updated on this site: 25 Nov 2024
To update sections 4.4 and 4.5 of SPC in line with reference product Securon SR (PL 46302/0027). Consequently, the PIL has been updated.
Additional editorial updates in the PIL.
Last updated on this site: 25 Nov 2024
To update sections 4.4 and 4.5 of SPC in line with reference product Securon SR (PL 46302/0027). Consequently, the PIL has been updated.
Additional editorial updates in the PIL.
-
Changes: (Updated: 25 Nov 2024)
To update sections 4.4 and 4.5 of SPC in line with reference product Securon SR (PL 46302/0027). Consequently, the PIL has been updated.
Additional editorial updates in the PIL.
-
Changes: (Updated: 07 Jul 2023)
Administrative changes only- no change to file.
-
Changes: (Updated: 06 Jul 2023)
Variation Description:
1) To update sections 4.3 and 4.8 of the SmPC and to update the PIL in line with the reference product (Securon SR 240mg Tablets, PL 46302/0027, MAH: Mylan Generics, SPC updated 05/08/2022).
2) To update section 4.4 of the SmPC and to update the PIL section 2 to include the sodium free statement, in line with the latest EC guidelines on excipients (EMA/CHMP/302620/2017). The cartons have been updated to remove non-compulsory excipients.
Additional updates have been made to the PIL to align the information with the SmPC and to bring in line with the latest QRD template (Version 10.3, 09/2022).
-
Changes: (Updated: 22 Sep 2022)
Initial upload